About Changi General Hospital
Changi General Hospital (CGH) is an academic medical institution with over 1,000 beds serving a community of more than 1 million people in
eastern Singapore. With a wide range of medical specialties and services, it is helmed by an experienced and skilled team of healthcare
professionals who consistently deliver positive health outcomes and care for patients.
About Shimadzu (Asia Pacific) Pte Ltd
Shimadzu (Asia Pacific) Pte. Ltd. is a subsidiary and the Asian headquarter of Shimadzu Corporation, which was founded in 1875 in Kyoto,
Japan. The subsidiary was established in 1989 in Singapore as a distribution centre providing analytical solutions, scientific equipment, testing
and NDI machines, balances and medical equipment to a wide range of laboratories. A fast-paced growth of business in the region has seen
the opening of 4 subsidiaries in India, Malaysia, Philippines and Vietnam with application specialists, technical and sales engineers operating
across 18 countries throughout the region including, Singapore, Bangladesh, Bhutan, Brunei, Cambodia, East Timor, Indonesia, Laos, Maldives,
Myanmar, Nepal, Pakistan, Sri Lanka and Thailand. Additionally, the company operates via a wide and carefully selected network of local
distributors in every country in the region.
The company's instruments are relied upon by researchers all across Asia from large multinational organisations to local academic research
universities and a long list of local, state and central laboratories. Through adoption of scientific inventions and cutting-edge technologies,
Shimadzu (Asia Pacific) provides its customers with the highest quality in product standards and delivers excellent customer support services
in accordance with its motto - 'Excellence in Science'.
For media inquiries, please contact:
Changi General Hospital
Teo Yin Yin
Contact: (65) 6936 6935
Shimadzu (Asia Pacific) Pte Ltd
Saptarshi Chaudhuri (Bob)
Contact: (65) 9273 6168
Laragh J.H; Sealey J.E. (2011) The Plasma Renin Test Reveals the Contribution of Body Sodium-Volume Content (V) and Renin-Angiotensin (R)
Vasoconstriction to Long-Term Blood Pressure. American Journal of Hypertension. 1165.